PORTAGE BIOTECH INC. 1,000,000 Ordinary Shares (no par value per share) Underwriting AgreementPortage Biotech Inc. • June 24th, 2021 • Crude petroleum & natural gas • New York
Portage Biotech Inc., a British Virgin Islands company (the "Company"), proposes to issue and sell to the several underwriters named in Schedule A (the "Underwriters") an aggregate of 1,000,000 shares (the "Shares") of its ordinary shares, no par value per share (the "Ordinary Shares"). The 1,000,000 Shares to be sold by the Company are called the "Firm Shares." In addition, the Company has granted to the Underwriters an option to purchase up to an additional 1,000,000 Shares pursuant to such option are collectively called the "Option Shares." The Firm Shares and, if and to the extent such option is exercised, the Option Shares, are collectively called the "Offered Shares." Cantor Fitzgerald & Co. ("Cantor") has agreed to act as representative of the several Underwriters (in such capacity, the "Representative") in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term "Representative" as used herein
